Rosen, N., Pearlman, E., Ruff, D., Day, K., & Nagy, A. J. (2019). Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine. Headache.
Citação norma ChicagoRosen, Noah, Eric Pearlman, Dustin Ruff, Kathleen Day, and Abraham Jim Nagy. "Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine." Headache 2019.
Citação norma MLARosen, Noah, et al. "Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine." Headache 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.